Clinical Trials Directory

Trials / Completed

CompletedNCT06868810

Comparison of 5% Nacl and 10% NaHCO3 As Contrast Agents for Lung Perfusion with EIT

Comparison of 5% Sodium Bicarbonate and 10% Sodium Chloride As Contrast Agents for Lung Perfusion with Electrical Impedance Tomography: a Prospective Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Not accepted

Summary

Electrical impedance tomography (EIT) has enabled the bedside monitoring of lung perfusion measurement through the indicator-based contrast method. Currently, hypertonic sodium chloride is the most commonly used contrast agent for lung perfusion evaluation by EIT. However, concerns may be raised regarding the potential risks of hyperchloremia and possible acute kidney injury associated with the use of hypertonic NaCl. Recently, two experimental studies found sodium bicarbonate (NaHCO3) might be an alternative to hypertonic sodium chloride in lung perfusion assessment by EIT. However, whether NaHCO3 results in acceptable bias is unknown in critically ill patients. This clinical study aimed to further investigate the correlation and agreement of lung perfusion and Ventilation/perfusion (V/Q) match by EIT contrast method between two contrast indicators (5%NaHCO3 vs. 10% NaCl) in critically ill patients with respiratory failure.

Conditions

Interventions

TypeNameDescription
OTHERInjection of hypertonic salineInjection 10 mL of 10% NaCl through central venous catheter
OTHERInjection of 5% NaHCO3Injection of 5% NaHCO3 through central venous catheter

Timeline

Start date
2024-04-01
Primary completion
2024-07-14
Completion
2024-08-26
First posted
2025-03-11
Last updated
2025-03-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06868810. Inclusion in this directory is not an endorsement.